Christopher R. Fenimore - Net Worth and Insider Trading

Christopher R. Fenimore Net Worth

The estimated net worth of Christopher R. Fenimore is at least $13 Million dollars as of 2024-12-28. Christopher R. Fenimore is the SVP Finance & CFO of Regeneron Pharmaceuticals Inc and owns about 18,767 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $13 Million. Details can be seen in Christopher R. Fenimore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher R. Fenimore has not made any transactions after 2024-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher R. Fenimore

To

Christopher R. Fenimore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher R. Fenimore owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .

Click here to see the complete history of Christopher R. Fenimore’s form 4 insider trades.

Insider Ownership Summary of Christopher R. Fenimore

Ticker Comapny Transaction Date Type of Owner
REGN Regeneron Pharmaceuticals Inc 2024-08-28 VP & Controller

Christopher R. Fenimore Latest Holdings Summary

Christopher R. Fenimore currently owns a total of 1 stock. Christopher R. Fenimore owns 18,767 shares of Regeneron Pharmaceuticals Inc (REGN) as of August 28, 2024, with a value of $13 Million.

Latest Holdings of Christopher R. Fenimore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
REGN Regeneron Pharmaceuticals Inc 2024-08-28 18,767 712.40 13,369,611

Holding Weightings of Christopher R. Fenimore


Christopher R. Fenimore Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher R. Fenimore has made a total of 11 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 5,680 shares on August 28, 2024, which brought Christopher R. Fenimore around $7 Million.

Insider Trading History of Christopher R. Fenimore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher R. Fenimore Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher R. Fenimore Ownership Network

Ownership Network List of Christopher R. Fenimore

No Data

Ownership Network Relation of Christopher R. Fenimore

Insider Network Chart

Christopher R. Fenimore Owned Company Details

What does Regeneron Pharmaceuticals Inc do?

Who are the key executives at Regeneron Pharmaceuticals Inc?

Christopher R. Fenimore is the VP & Controller of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , EVP Research Andrew J Murphy , and SVP & Preclinical Development Neil Stahl .

Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary

Over the past 18 months, Christopher R. Fenimore made 4 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 14,977. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,564 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .

In summary, during the past 3 months, insiders sold 2,100 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 2,100 shares. During the past 18 months, 315,669 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,669 shares.

Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regeneron Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher R. Fenimore Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher R. Fenimore. You might contact Christopher R. Fenimore via mailing address: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown Ny 10591.

Discussions on Christopher R. Fenimore

No discussions yet.